Imaging Biometrics Limited IBAI
LSE · United Kingdom · Technology Services
GBp 1.000.00 (0.00%)
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · GBp · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Imaging Biometrics Ltd (LSE:IBAI, FRA:5Y1) has published positive Phase 1 results for its oral gallium maltolate treatment in recurrent glioblastoma, with the drug found safe and well tolerated at all dose levels. One patient has now been on treatment for more than 38 months, and the company is reactivating its Expanded Access Programme for up to 20 additional patients. Rome Resources Plc (AIM:RMR) is launching its first field programme as operator at its New Brunswick tin-tungsten-indium project in Canada this week, with more than 500 samples planned across three priority targets. The company
KEFI Gold and Copper PLC (AIM:KEFI) has added a US$20 million equity-ranking royalty to fund its Tulu Kapi gold project in Ethiopia. It says the US$340 million package is now covered, with contractors mobilised and ground broken. Pan African Resources PLC (AIM:PAF, JSE:PAN) expects a sharp jump in half-year earnings. EPS is seen at over 7 US cents, helped by higher gold prices and 51% more production. Seeing Machines Ltd (AIM:SEE, OTC:SEEMF, FRA:M2Z) produced nearly 580,000 vehicles with its driver-monitoring systems in the second quarter of its 2026 financial year. It says demand is building
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.